Golden Life Pharmaceutical Group (01110.HK) terminates the acquisition of a Hong Kong pharmaceutical company.

Zhito Financial News App News, Jinhuo Pharmaceutical Group (01110.HK) announced that its wholly-owned subsidiary Jinhuo Pharmaceutical Health Group Limited (Jinhuo Pharmaceutical (BVI)), the proposed seller (proposed seller), and guarantor have terminated the memorandum of understanding regarding the proposed acquisition of the target company's entire issued share capital. Jinhuo Pharmaceutical (BVI) has exercised its right to terminate the memorandum of understanding in accordance with its terms, effective immediately on June 15, 2026.